Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Draft Guidance Offers Clarity On 510(k) Need for Software Modifications

Executive Summary

FDA has outlined its thinking on when companies should consider filing a 510(k) when they make a software change to a medical device or software that acts as a standalone device.

Advertisement

Related Content

Despite 510(k) Software Guidance, US FDA's Hands May Still Be Tied
Get 'HIP'AA To Digital Medtech Law: More Than Just FDA To Worry About
FDA Provides Accessories Guidance, But May Be 'Missed' Opportunity
FDA Calls For Full Risk Reviews For Device Changes In 510(k) Modifications Draft

Topics

Advertisement
UsernamePublicRestriction

Register

MT103697

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel